Top

Published in:

Open Access 01-02-2009 | Original Article

Effects of Macroplastique^® Implantation System for stress urinary incontinence and urethral hypermobility in women

Authors: Ph. H. ter Meulen, L. C. M. Berghmans, F. H. M. Nieman, Ph. E. V. A. van Kerrebroeck

Published in: International Urogynecology Journal | Issue 2/2009

Abstract

A study was carried out to evaluate efficacy of Macroplastique® (MPQ) Implantation System (MIS) in women with urodynamic stress urinary incontinence (SUI) and urethral hypermobility after an unsuccessful conservative treatment. This is a prospective randomized controlled trial in women without previous incontinence surgery. Twenty-four women received MPQ. Twenty-one controls underwent a pelvic floor muscle exercises home program. Follow-up was at 3 months and the MPQ group also at 12 months. At 3 months, pad usage decreased significantly more in the MPQ group than in the control group (p = 0.015). According to physician and patient self-assessment, respectively, 71% and 63% women in the MPQ group were considered cured or markedly improved. This was significantly higher compared to controls. There was a significant higher increase of Incontinence Quality-of-Life questionnaire score in the MPQ group compared to controls (p = 0.017). Improvements in MPQ group at 3 months are sustained to 12 months. Adverse events were mild and transient. MIS is an acceptable option for women with SUI and urethral hypermobility.

Shah J (1997) Injectables and stress urinary incontinence. Urol News 2:7–11

Chapple CR, Wein AJ, Brubaker L, Dmochowski R, Espuna Pons M, Haab F, Hill Sl (2005) Stress incontinence injection therapy: what is the best for our patients? Eur Urol 48:552–565PubMedCrossRef

Tamanini JT, D’Ancona CA, Netto NR (2006) Macroplastique implantation system for female stress urinary incontinence: long term follow-up. J Endourol 20(12):82–86CrossRef

Herschorn S, Radomski SB, Steele DJ (1992) Early experience with intraurethral collagen injections for urinary incontinence. J Urol 148:1797–1800PubMed

Bent AE, Foote JE, Siegel S, Faerber G, Chao R, Gormley EA (2001) Collagen implant in treating stress urinary incontinence in women with urethral hypermobility. J Urol 164(4):1354–1357

Steele AC, Kohli N, Karram MM (2000) Periurethral collagen injection for stress incontinence with and without urethral hypermobility. Obstet Gynecol 95:327–331PubMedCrossRef

Harriss DR, Iacovou JW, Lemberger RJ (1996) Periurethral silicone microimplants (Macroplastique) for the treatment of genuine stress incontinence. Br J Urol 78:722–728PubMed

Koelbl H, Saz V, Doerfler D, Haeusler G, Sam Ch, Hanzal E (1998) Transurethral injection of silicone microimplants for intrinsic urethral sphincter deficiency. Obstet Gynecol 92:332–336PubMedCrossRef

ter Meulen PhH, Berghmans LCM, van Kerrebroeck PhEVA (2003) Systematic review: efficacy of silicone microimplants (Macroplastique®) therapy for stress urinary incontinence in adult women. Eur Urol 44:573–582PubMedCrossRef

10.

Solomon LZ, Birch BR, Cooper AJ, Davies CL, Holmes SAV (2000) Nonhomologous bioinjectable materials in urology: ‘size matters’? BJU Int 85:641–645PubMedCrossRef

11.

Allen O (1992) Response to subdermal implantation of textured microimplants in humans. Aesth Plast Surg 16:227–230CrossRef

12.

Smith DP, Kaplan WE, Oyasu R (1994) Evaluation of polydimethylsiloxane as an alternative in the endoscopic treatment of vesicoureteral reflux. J Urol 152:1221–1224PubMed

13.

Henly DR, Barrett DM, Weiland TL, O’Connor MK, Malizia AA, Wein AJ (1995) Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J Urol 153:2039–2043PubMedCrossRef

14.

Radley SC, Chapple CR, Lee JA (2000) Transurethral implantation of silicone polymer for stress incontinence: evaluation of a porcine model and mechanism of action in vivo. BJU Int 85:646–650PubMedCrossRef

15.

World Medical Association (2002) Declaration of Helsinki (Document 17.C), World Medical Association, Note on Paragraph 29, 6.10.2002

16.

Stamey TA (1979) Urinary incontinence in the female. Campbell’s urology, fourth edn. Saunders, New York, pp 2272–2293

17.

Abrams P, Blaivas JG, Stanton SL, Anderson JT (1988) The standardization of terminology of lower urinary tract function. The International Continence Society Committee on Standardization of Terminology. Scand J Urol Nephrol 114(suppl):5–19

18.

Bump RC, Mattiasson A, Bo K, Brubaker LP, Delancey JOL, Klarskov P et al (1996) The standardization of terminology of female organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175:10–17PubMedCrossRef

19.

Patrick DL, Martin ML, Buschnell DM, Yalcin I, Wagner TH, Buesching DP (1999) Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL). Urology 53:71–76PubMedCrossRef

20.

Crystle CD, Charme LS, Copeland WE (1971) Q-tip test in stress urinary incontinence. Obstet Gynecol 38:313–315PubMed

21.

Cummings JM (1997) Leak point pressures in female stress urinary incontinence. Int Urogynaecol J 8:153–155CrossRef

22.

Henalla SM, Hall V, Duckett JRA, Link C, Usman F, Tromans PM et al (2000) A multicentre evaluation of a new surgical technique for urethral bulking in the treatment of genuine stress incontinence. Br J Obstet Gynecol 107:1035–1039

23.

SPSS (2006) SPSS 15.0 for Windows. SPSS, Chicago

24.

Jorgensen L, Steen A, Bagger PV, Fisher-Rasmussen W (1985) The one-hour pad-weighing test for assessment of the result of female incontinence surgery. In: Proceedings of the 15th Annual Meeting of the International Incontinence Society; London, pp 392–393

25.

Lose G, Gammelgaard J, Jorgensen TJ (1986) The one-hour-hour pad weighing test: reproducibility and the correlation between the best result, the start volume in the bladder and the diuresis. Neurourol Urodyn 5:17–21CrossRef

26.

Lose G, Jorgensen L, Thunedborg P (1989) 24-hour home pad weighing test versus 1-hour ward test in the assessment of mild stress incontinence. Acta Obstet Gynecol Scand 68:211–215PubMedCrossRef

27.

Simons AM, Yoong WC, Buckland S, Moore KH (2001) Inadequate repeatability of the one-hour pad test: the need for a new incontinence outcome measure. Br J Obstet Gynecol 108:315–319CrossRef

28.

ter Meulen PhH, van Kerrebroeck PhEVA (2004) Injection therapy for stress urinary incontinence in adult women. Expert Rev Med Devices 1:89–97CrossRef

29.

Costantini E, Lazzeri M, Porena M (2007) Managing complications after midurethral sling for stress urinary incontinence. Eur Urol Update Series 5:232–240

30.

Robinson D, Anders K, Cardozo L, Bidmead J, Dixon A, Balmforth J et al (2003) What do women want? Interpretation of the concept of cure. J Pelvic Med Surg 9:273–277CrossRef

Title: Effects of Macroplastique® Implantation System for stress urinary incontinence and urethral hypermobility in women
Authors: Ph. H. ter Meulen
L. C. M. Berghmans
F. H. M. Nieman
Ph. E. V. A. van Kerrebroeck
Publication date: 01-02-2009
Publisher: Springer-Verlag
Published in: International Urogynecology Journal / Issue 2/2009
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-008-0741-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effects of Macroplastique^® Implantation System for stress urinary incontinence and urethral hypermobility in women

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2009

Transient obturator neuropathy due to local anesthesia during transobturator sling placement

The impact of TVT on sexual function

Is there any evidence to advocate SUI prevention in continent women undergoing prolapse repair? An overview

Dynamic magnetic resonance imaging: reliability of anatomical landmarks and reference lines used to assess pelvic organ prolapse

Urinary retention is uncommon after colpocleisis with concomitant mid-urethral sling

Protective action of intravesical oxybutynin on bladder ultrastructure in rabbits with detrusor overactivity